Research details developments in the Cancer Cachexia – Pipeline Review, H2 2016


“The Report Cancer Cachexia – Pipeline Review, H2 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

Global Markets Directs, Cancer Cachexia – Pipeline Review, H2 2016, provides an overview of the Cancer Cachexia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cancer Cachexia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cancer Cachexia and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at :


– The report provides a snapshot of the global therapeutic landscape of Cancer Cachexia

– The report reviews pipeline therapeutics for Cancer Cachexia by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Cancer Cachexia therapeutics and enlists all their major and minor projects

– The report assesses Cancer Cachexia therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Cancer Cachexia

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Cancer Cachexia

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Cancer Cachexia pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 7

Introduction 8

Global Markets Direct Report Coverage 8

Cancer Cachexia Overview 9

Therapeutics Development 10

Pipeline Products for Cancer Cachexia – Overview 10

Pipeline Products for Cancer Cachexia – Comparative Analysis 11

Cancer Cachexia – Therapeutics under Development by Companies 12

Cancer Cachexia – Therapeutics under Investigation by Universities/Institutes 14

Cancer Cachexia – Pipeline Products Glance 15

Late Stage Products 15

Clinical Stage Products 16

Early Stage Products 17

Cancer Cachexia – Products under Development by Companies 18

Cancer Cachexia – Products under Investigation by Universities/Institutes 19

Cancer Cachexia – Companies Involved in Therapeutics Development 20

Acacia Pharma Limited 20

Aeterna Zentaris Inc. 21

Aphios Corporation 22

Atara Biotherapeutics, Inc. 23

Eli Lilly and Company 24

Helsinn Healthcare S.A. 25

Incyte Corporation 26

Lakewood-Amedex Inc 27

Novartis AG 28

Obexia AG 29

PsiOxus Therapeutics Limited 30

RaQualia Pharma Inc. 31

Viking Therapeutics, Inc. 32

Cancer Cachexia – Therapeutics Assessment 33

Assessment by Monotherapy Products 33

Assessment by Combination Products 34

Assessment by Target 35

Assessment by Mechanism of Action 38

Assessment by Route of Administration 41

Assessment by Molecule Type 43

Drug Profiles 45

(formoterol fumarate + megestrol acetate) – Drug Profile 45

Product Description 45

Mechanism Of Action 45

R&D Progress 45

anamorelin hydrochloride – Drug Profile 46

Product Description 46

Mechanism Of Action 46

R&D Progress 46

Follow us on LinkedIn:

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074